Strides Pharma Science Limited Share Price

Equities

STAR

INE939A01011

Pharmaceuticals

Market Closed - NSE India S.E. 05:13:49 26/04/2024 pm IST 5-day change 1st Jan Change
876.7 INR -0.76% Intraday chart for Strides Pharma Science Limited +3.94% +35.03%
Sales 2024 * 41.14B 493M Sales 2025 * 45.13B 541M Capitalization 80.57B 966M
Net income 2024 * -414M -4.97M Net income 2025 * 2.92B 35.03M EV / Sales 2024 * 1.96 x
Net cash position 2024 * - 0 Net cash position 2025 * - 0 EV / Sales 2025 * 1.79 x
P/E ratio 2024 *
-191 x
P/E ratio 2025 *
21.6 x
Employees 2,850
Yield 2024 *
0.41%
Yield 2025 *
0.41%
Free-Float 68.29%
More Fundamentals * Assessed data
Dynamic Chart
1 day-0.76%
1 week+3.94%
Current month+11.72%
1 month+13.48%
3 months+27.74%
6 months+84.34%
Current year+35.03%
More quotes
1 week
811.50
Extreme 811.5
902.40
1 month
776.60
Extreme 776.6
902.40
Current year
643.80
Extreme 643.8
902.40
1 year
330.00
Extreme 330
902.40
3 years
263.35
Extreme 263.35
909.75
5 years
263.35
Extreme 263.35
999.00
10 years
263.35
Extreme 263.35
1 414.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 63 28/90/28
Director of Finance/CFO - 01/10/01
Compliance Officer - 03/17/03
Members of the board TitleAgeSince
Chief Executive Officer 63 28/90/28
Director/Board Member 80 18/17/18
Director/Board Member 63 27/12/27
More insiders
Date Price Change Volume
26/24/26 876.7 -0.76% 150,685
25/24/25 883.4 +0.20% 185,948
24/24/24 881.7 -1.30% 235,028
23/24/23 893.4 +5.90% 877,049
22/24/22 843.6 +0.02% 166,028

Delayed Quote NSE India S.E., April 26, 2024 at 05:13 pm IST

More quotes
Strides Pharma Science Limited is an India-based pharmaceutical company. The Company is focused on the development and manufacture of IP-led niche and pharmaceutical products. The Company operates through two segments: Pharmaceutical and Bio-pharmaceutical. Its geographical segment includes Africa, Australia, Asia (excluding India), North America, Europe, India, and Others. The Company manufactures a range of niche and pharmaceutical products, including a range of dosage forms such as liquids, creams and ointments, soft gels, sachets, tablets, and modified release dosage formats. It has eight manufacturing units located in India (Bengaluru-two sites, Puducherry, and Chennai), Singapore, Italy (Milan), the United States (Florida) and Kenya (Nairobi). It is also engaged in manufacturing soft gelatin capsules. It develops and manufactures drugs in the anti-retroviral, anti-malarial, anti-tuberculosis, hepatitis, and other infectious disease drug segments for its institutional business.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
876.7 INR
Average target price
830.5 INR
Spread / Average Target
-5.27%
Consensus

Quarterly revenue - Rate of surprise